Cancer treatment in India is not only cheaper but in most cases the prognosis is amongst the best in the world.
It is vital for oncologists to get clinically actionable and timely results to decide on treatment options for patients. Keeping this in mind, StrandAdvantage, a tumor genomic profiling test by Strand Life Sciences, was launched in India about a year ago.
Strand Life Sciences is a global genomic profiling & bioinformatics company focusing on the use of precision medicine diagnostics aimed at cancer care and inherited diseases.In 2016, Strand made its new 152-gene test available to physicians across India for expanded tumor profiling, compared to the existing Tissue-Specific Tests for colon, lung, and breast cancers, and the 48-gene test for rare and aggressive cancers.
Breast cancer is one of the most common cancers affecting women, but did you know that there are various types of breast cancers. One such type is HER2-positive breast cancer,…
A utopia, in which all the published data (new and existing) related to medical field is assimilated, understood and provides insights, could be a reality very soon. Cognitive computing technology could be the next transformative force propelling the healthcare industry towards the next era. In 2015, near 44, 000 oncology research papers were published globally which mounts down to almost 122 new papers per day. Not even the best of human mind can tackle this tsunami of data let alone utilization of this for providing more efficient treatment to the patients. A technology which can help the doctors to utilize this vast amount of data for the benefit of the patients could be a game changer.
Chemotherapy is one of the treatment options that offer hope to many women with breast cancer. But it can also cause some unwanted side effects ranging from hair loss and constipation, to more serious complications. Accepting a diagnosis of breast cancer is difficult enough, and to add to that, the side effects related to its treatment can sometimes further demotivate patients.